Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)

BACKGROUND: Peripheral biomarkers that identify individuals at risk of developing Alzheimer’s disease (AD) or predicting high amyloid beta (Aβ) brain burden would be highly valuable. To facilitate clinical trials of disease-modifying therapies, plasma concentrations of Aβ species are good candidates...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rojas, Itziar, Romero, J., Rodríguez-Gomez, O., Pesini, P., Sanabria, A., Pérez-Cordon, A., Abdelnour, C., Hernández, I., Rosende-Roca, M., Mauleón, A., Vargas, L., Alegret, M., Espinosa, A., Ortega, G., Gil, S., Guitart, M., Gailhajanet, A., Santos-Santos, M. A., Moreno-Grau, Sonia, Sotolongo-Grau, O., Ruiz, S., Montrreal, L., Martín, E., Pelejà, E., Lomeña, F., Campos, F., Vivas, A., Gómez-Chiari, M., Tejero, M. A., Giménez, J., Pérez-Grijalba, V., Marquié, G. M., Monté-Rubio, G., Valero, S., Orellana, A., Tárraga, L., Sarasa, M., Ruiz, A., Boada, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267075/
https://www.ncbi.nlm.nih.gov/pubmed/30497535
http://dx.doi.org/10.1186/s13195-018-0444-1

Ejemplares similares

Ejemplares similares